Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02221518 · ClinicalTrials.gov registry record · NA
Control and Reward Circuits in Obsessive Compulsive Disorder
A NA study, sponsored by New York State Psychiatric Institute.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT02221518 is a NA study that has completed, run by New York State Psychiatric Institute. The registered enrollment target is 80 participants.
The verdict
NCT02221518, a NA study, has completed, sponsored by New York State Psychiatric Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the brain functioning of OCD patients and healthy controls before and after treatment with Exposure and Response Prevention (EXRP) therapy.
Interventions
- BEHAVIORAL Exposure & Response Prevention (EX/RP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2014-10 |
| Est. Completion | 2018-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02221518
The ClinicalTrials.gov registry entry for NCT02221518 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Exposure & Response Prevention (EX/RP) is the first listed.
NCT02221518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02221518 about?
NCT02221518 is a clinical study titled "Control and Reward Circuits in Obsessive Compulsive Disorder". The purpose of this study is to examine the brain functioning of OCD patients and healthy controls before and after treatment with Exposure and Response Prevention (EXRP) therapy.
What is the current status of trial NCT02221518?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2014-10. Estimated completion is 2018-08.
What interventions are being tested in trial NCT02221518?
The interventions under investigation include: Exposure & Response Prevention (EX/RP) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02221518?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.